NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-031-2006-0-EP-04 Chlamydia Vaccine EP National Stage 07717780.6 Abandoned
NIAID E-031-2006-0-DE-06 Chlamydia Vaccine DE EP 07717780.6 Abandoned
NIAID E-031-2006-0-FR-07 Chlamydia Vaccine FR EP 07717780.6 Abandoned
NIAID E-031-2006-0-GB-08 Chlamydia Vaccine GB EP 07717780.6 Abandoned
NIAID E-031-2006-0-PCT-02 Chlamydia Vaccine PCT PCT PCT/US2007/001213 Expired
NIAID E-267-2004-1-US-08 VACCINES AGAINST AIDS COMPRISING CMV/R-NUCLEIC ACID CONSTRUCTS US National Stage 11/632,522 Abandoned
NCI E-085-2007-0-US-01 Methods of Determining the Prognosis of an Adenocarcinoma US 60/885,101 Abandoned
NCI E-275-2007-0-US-01 CD45, A Protein Tyrosine Phosphatase As A Therapeutic Target For Multiple Pathogenic Organisms US 60/644,931 Abandoned
NCI E-254-2005-2-EP-06 CODON OPTIMIZED IL-15 AND IL-15R-ALPHA GENES FOR EXPRESSION IN MAMMALIAN CELLS EP National Stage 07716564.5 Issued
NCI E-254-2005-2-EP-13 Improved IL-15 for Expression in Mammalian Cells EP DIV 11154217.1 Issued
NCI E-254-2005-2-CA-04 CODON OPTIMIZED IL- 15 AND IL- 15R-ALPHA GENES FOR EXPRESSION IN MAMMALIAN CELLS CA National Stage 2636111 Issued
NCI E-254-2005-2-CN-16 CODON OPTIMIZED IL-15 AND IL-15R ALPHA GENES FOR EXPRESSION IN MAMMALIAN CELLS CN DIV 201210119215.6 Issued
NCI E-254-2005-2-JP-09 CODON OPTIMIZED IL-15 AND IL-15R-ALPHA GENES FOR EXPRESSION IN MAMMALIAN CELLS JP National Stage 2008-550416 Issued
NCI E-254-2005-2-AU-02 Codon Optimized IL-15 and IL-15R Alpha Genes for Expression in Mammalian Cells AU National Stage 2007207785 Issued
NCI E-254-2005-2-CN-05 CODON OPTIMIZED IL-15 AND IL-15R-ALPHA GENES FOR EXPRESSION IN MAMMALIAN CELLS CN National Stage 200780003101.2 Issued
NCI E-254-2005-2-MX-10 Improved IL-15 for Expression in Mammalian Cells MX National Stage MX/a/2008/008940 Issued
NCI E-267-2005-0-PCT-02 Improved IL-12 for Expression in Mammalian Cells PCT PCT PCT/US2007/000825 Expired
NCI E-254-2005-2-PCT-01 Codon Optimized IL-15 and IL-15R-Alpha Genes for Expression in Mammalian Cells PCT PCT COMB PCT/US2007/000774 Expired
NCI E-254-2005-2-BR-03 CODON OPTIMIZED IL-15 AND IL-15R-ALPHA GENES FOR EXPRESSION IN MAMMALIAN CELLS BR National Stage PI0707106-0 Pending
NCI E-059-2007-0-US-01 GP100-Specific T Cell Receptors and Related Materials and Methods of Use US 60/884,732 Abandoned
NCI E-286-2006-1-US-01 SCGB3A2 as a Growth Factor and Anti-Apoptotic Agent US 60/880,134 Abandoned
NIDDK E-021-2007-0-US-01 Methods to Identify Inhibitors of Cell Sickling US ORD 11/652,843 Abandoned
NIAID E-046-2007-0-US-01 Method for Rapid Detection of Clostridium Botulinum US 60/884,539 Abandoned
NIAMS E-011-2007-0-US-01 Blockade Of TL1A-DR3 Interactions To Ameliorate T-Cell Mediated Disease Pathology US 60/879,668 Abandoned
NCI E-249-2004-1-US-02 DNA-Based Vaccination of Retroviral-Infected Individuals Undergoing Treatment US National Stage 11/571,879 Abandoned
NCI E-050-2007-0-US-01 Methods of Determining the Prognosis of Hepatocellular Carcinoma US 60/884,052 Abandoned
NCI E-285-2006-1-US-01 Organ And Tumor Associated Endothelial Markers US 60/879,457 Abandoned
NCI E-083-2007-0-US-01 Use Of SLCOlB3 Genotyping To Predict A Survival Prognosis Of Prostate Cancer US 60/879,503 Abandoned
NCI E-347-2003-3-US-03 SUBSET OF COMPOSITE ANTIBODIES Of Hum Subgroup IV Light Chain Capable Of Binding To TAG-72 US CON 11/651,407 Expired
NCI E-181-2006-0-CN-17 MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Lung Cancer CN DIV 201410210166.6 Abandoned
NCI E-181-2006-0-EP-12 MicroRNA-based methods for the diagnosis, prognosis and treatment of lung cancer EP DIV 12165740.7 Abandoned
NCI E-181-2006-0-GB-35 MicroRNA-based methods for the diagnosis, prognosis and treatment of lung cancer GB EP 12165740.7 Abandoned
NCI E-181-2006-0-DE-34 MicroRNA-based methods for the diagnosis, prognosis and treatment of lung cancer DE EP 12165740.7 Abandoned
NCI E-181-2006-0-DE-32 MicroRNA-based methods for the diagnosis, prognosis and treatment of lung cancer DE EP 12165734.0 Abandoned
NCI E-181-2006-0-EP-11 MicroRNA-based methods for the diagnosis, prognosis and treatment of lung cancer EP DIV 12165734.0 Abandoned
NCI E-181-2006-0-GB-33 MicroRNA-based methods for the diagnosis, prognosis and treatment of lung cancer GB EP 12165734.0 Abandoned
NCI E-181-2006-0-GB-39 MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer GB EP 12165748.0 Abandoned
NCI E-181-2006-0-CH-36 MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer CH EP 12165748.0 Abandoned
NCI E-181-2006-0-DE-37 MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer DE EP 12165748.0 Abandoned
NCI E-181-2006-0-FR-38 MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer FR EP 12165748.0 Abandoned
NCI E-181-2006-0-EP-13 MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer EP DIV 12165748.0 Abandoned
NCI E-181-2006-0-IT-40 MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer IT EP 12165748.0 Abandoned
NCI E-181-2006-0-JP-08 MicroRNA-based Methods and Compositions for the Diagnosis, Prognosis, And Treatment of Lung Cancer JP National Stage 2008-549549 Abandoned
NCI E-181-2006-0-IT-31 MICRORNA-BASED METHODS FOR THE DIAGNOSIS AND PROGNOSIS OF LUNG CANCER IT EP 07717734.3 Abandoned
NCI E-181-2006-0-GB-30 MICRORNA-BASED METHODS FOR THE DIAGNOSIS AND PROGNOSIS OF LUNG CANCER GB EP 07717734.3 Abandoned
NCI E-181-2006-0-CH-26 MICRORNA-BASED METHODS FOR THE DIAGNOSIS AND PROGNOSIS OF LUNG CANCER CH EP 07717734.3 Abandoned
NCI E-181-2006-0-EP-07 MICRORNA-BASED METHODS FOR THE DIAGNOSIS AND PROGNOSIS OF LUNG CANCER EP National Stage 07717734.3 Abandoned
NCI E-181-2006-0-FR-29 MICRORNA-BASED METHODS FOR THE DIAGNOSIS AND PROGNOSIS OF LUNG CANCER FR EP 07717734.3 Abandoned
NCI E-181-2006-0-DE-27 MICRORNA-BASED METHODS FOR THE DIAGNOSIS AND PROGNOSIS OF LUNG CANCER DE EP 07717734.3 Abandoned
NCI E-181-2006-0-ES-28 MICRORNA-BASED METHODS FOR THE DIAGNOSIS AND PROGNOSIS OF LUNG CANCER ES EP 07717734.3 Abandoned